Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hypersensitivity Reaction

Free Subscription Articles published in Lancet Retrieve available abstracts of 12 articles: HTML format

Single Articles

November 2025
1. GUTTMAN-YASSKY E, Kabashima K, Worm M, Luna PC, et al
   Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.
   Lancet. 2025 Nov 25:S0140-6736(25)01865-3. doi: 10.1016/S0140-6736(25)01865.
   PubMed     Abstract available
   
   
   
2. ATASH K, Boesjes CM, de Bruin-Weller MS
   Targeting OX40: rocatinlimab-a novel therapy for atopic dermatitis.
   Lancet. 2025 Nov 25:S0140-6736(25)02152-X. doi: 10.1016/S0140-6736(25)02152.
   PubMed    
   
   
   
3. BIESIEKIERSKI JR, Jonkers D, Ciacci C, Aziz I, et al
   Non-coeliac gluten sensitivity.
   Lancet. 2025;406:2494-2508.
   PubMed     Abstract available
   
   
   September 2025
4. ISRAEL E, Wechsler ME, Jackson DJ, Moore WC, et al
   Anti-cytokine biologics for asthma in adults.
   Lancet. 2025 Sep 29:S0140-6736(25)01625-3. doi: 10.1016/S0140-6736(25)01625.
   PubMed     Abstract available
   
   
   
5. HATTER L, Holliday M, Oldfield K, Kearns C, et al
   Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
   Lancet. 2025 Sep 28:S0140-6736(25)00861-X. doi: 10.1016/S0140-6736(25)00861.
   PubMed     Abstract available
   
   
   February 2025
6. GUTTMAN-YASSKY E, Renert-Yuval Y, Brunner PM
   Atopic dermatitis.
   Lancet. 2025;405:583-596.
   PubMed     Abstract available
   
   
   December 2024
7. WEIDINGER S, Novak N
   Hand eczema.
   Lancet. 2024;404:2476-2486.
   PubMed     Abstract available
   
   
   November 2024
8. SOMA T, Oie Y, Takayanagi H, Matsubara S, et al
   Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery: a single-arm, open-label, first-in-human interventional study in Japan.
   Lancet. 2024 Nov 7:S0140-6736(24)01764-1. doi: 10.1016/S0140-6736(24)01764.
   PubMed     Abstract available
   
   
   July 2024
9. ZUBERBIER T, Ensina LF, Gimenez-Arnau A, Grattan C, et al
   Chronic urticaria: unmet needs, emerging drugs, and new perspectives on personalised treatment.
   Lancet. 2024;404:393-404.
   PubMed     Abstract available
   
   
   
10. BRUNNER PM
    A novel treatment approach for atopic dermatitis.
    Lancet. 2024 Jul 25:S0140-6736(24)01488-0. doi: 10.1016/S0140-6736(24)01488.
    PubMed    
    
    
    
11. SILVERBERG JI, Wollenberg A, Reich A, Thaci D, et al
    Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
    Lancet. 2024 Jul 24:S0140-6736(24)01203-0. doi: 10.1016/S0140-6736(24)01203.
    PubMed     Abstract available
    
    
    February 2024
12. ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al
    The INSPIRE study: RSV infection during infancy - Authors' reply.
    Lancet. 2024;403:729-730.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.